Crispr Therapeutics (CRSP)
NASDAQ:CRSP
Want to see CRSP full AI Analyst Report?
Crispr Therapeutics AG (CRSP) Ownership Overview
2.54% Insiders
14.25% Mutual Funds
43.95% Other Institutional Investors
18.99% ETFs
20.27% Public Companies and Individual Investors
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail, and individual investors. Approximately 77.19% of the company’s stock is owned by Institutional Investors, 2.54% is owned by Insiders, and 20.27% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 27, 2026 | xxxxxxxxxxxxx | $49704 | |
Aug 08, 2025 | xxxxxxxxxxxxx | $1140600 | |
Jul 17, 2025 | xxxxxxxxxxxxx | $51499918 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $1174265 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $538189046 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $90383 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,313,623 | Institution | 11.73% | 611,953,868 | |
| 8,572,255 | Institution | 8.89% | 463,673,273 | |
| 4,184,950 | Institution | 4.34% | 226,363,946 | |
| 2,158,671 | Institution | 2.24% | 116,762,514 | |
| 2,038,763 | Insider | 2.11% | 110,276,691 | |
| 1,944,073 | Institution | 2.02% | 105,154,909 | |
| 1,659,980 | Institution | 1.72% | 89,788,318 | |
| 1,647,885 | Institution | 1.71% | 89,134,100 | |
| 1,414,053 | Institution | 1.47% | 76,486,127 | |
| 1,072,377 | Institution | 1.11% | 58,004,872 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,944,073 | Institution | 2.02% | 105,154,909 | |
| 1,647,885 | Institution | 1.71% | 89,134,100 | |
| 1,414,053 | Institution | 1.47% | 76,486,127 | |
| 1,072,377 | Institution | 1.11% | 58,004,872 | |
| 1,050,900 | Institution | 1.09% | 56,843,181 | |
| 969,968 | Institution | 1.01% | 52,465,569 | |
| 964,697 | Institution | 1.00% | 52,180,461 | |
| 884,583 | Institution | 0.92% | 47,847,094 | |
| 613,007 | Institution | 0.64% | 33,157,549 | |
| 503,024 | Institution | 0.52% | 27,208,568 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,247,628 | Institution | 6.48% | 337,934,199 | |
| 2,136,476 | Institution | 2.22% | 115,561,987 | |
| 1,940,987 | Institution | 2.01% | 104,987,987 | |
| 1,910,395 | Institution | 1.98% | 101,422,871 | |
| 1,086,795 | Institution | 1.13% | 61,056,143 | |
| 794,028 | Institution | 0.82% | 42,948,975 | |
| 652,594 | Institution | 0.68% | 35,298,809 | |
| 469,564 | Institution | 0.49% | 26,380,106 | |
| 462,513 | Institution | 0.48% | 24,554,815 | |
| 299,884 | Institution | 0.31% | 16,220,726 |
FAQ
Who Owns Crispr Therapeutics (CRSP)?
According to the latest TipRanks data, approximately 43.95% of the company's stock is held by institutional investors, 2.54% is held by insiders, and 20.27% is held by retail investors.
What percentage of Crispr Therapeutics (CRSP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 43.95% of Crispr Therapeutics (CRSP) stock is held by institutional investors.
What percentage of Crispr Therapeutics (CRSP) stock is held by retail investors?
According to the latest TipRanks data, approximately 20.27% of Crispr Therapeutics (CRSP) stock is held by retail investors.
Who owns the most shares of Crispr Therapeutics (CRSP)?
Cathie Wood owns the most shares of Crispr Therapeutics (CRSP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.